SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001657312-19-000007
Filing Date
2019-03-19
Accepted
2019-03-19 12:42:46
Documents
145
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 20-F a2018veronapharma20-f.htm 20-F 2440097
2 EXHIBIT 4.3 renewalagreementoctober1.htm EX-4.3 32515
3 EXHIBIT 4.8 kathyrickardemploymentag.htm EX-4.8 28613
4 EXHIBIT 4.3.1 renewalagreementnovember.htm EX-4.3.1 25734
5 EXHIBIT 4.3.2 renewalagreementapril320.htm EX-4.3.2 36020
6 EXHIBIT 12.1 rule13a-certificationofceo.htm EX-12.1 10588
7 EXHIBIT 12.2 rule13acertificationofcfo.htm EX-12.2 10645
8 EXHIBIT 13.1 section1350ceo.htm EX-13.1 9743
9 EXHIBIT 13.2 section1350certificantiono.htm EX-13.2 6885
10 EXHIBIT 15.1 consentofpwc.htm EX-15.1 2448
17 a009relabelledtoensifentrine.jpg GRAPHIC 88466
18 a202changeinresidvol.jpg GRAPHIC 43856
19 a203ers4week.jpg GRAPHIC 93341
20 a203fev14weeka01.jpg GRAPHIC 104966
21 a204fev1day3.jpg GRAPHIC 90405
22 improvelfday3.jpg GRAPHIC 69592
23 kathyrickardemploymentag001.jpg GRAPHIC 179455
24 kathyrickardemploymentag002.jpg GRAPHIC 283412
25 kathyrickardemploymentag003.jpg GRAPHIC 289398
26 kathyrickardemploymentag004.jpg GRAPHIC 288177
27 kathyrickardemploymentag005.jpg GRAPHIC 265800
28 kathyrickardemploymentag006.jpg GRAPHIC 35122
29 kathyrickardemploymentag007.jpg GRAPHIC 208923
30 kathyrickardemploymentag008.jpg GRAPHIC 201713
31 kathyrickardemploymentag009.jpg GRAPHIC 30208
32 kathyrickardemploymentag010.jpg GRAPHIC 16968
33 kathyrickardemploymentag011.jpg GRAPHIC 18845
34 mediantimetoonsetday3.jpg GRAPHIC 67669
35 pde34activityfor20f.jpg GRAPHIC 88373
36 pipelinechart150219.jpg GRAPHIC 127793
37 pwclogo.jpg GRAPHIC 4761
38 reductionininflammatorycells.jpg GRAPHIC 42897
39 renewalagreementapril320001.jpg GRAPHIC 142332
40 renewalagreementapril320002.jpg GRAPHIC 413133
41 renewalagreementapril320003.jpg GRAPHIC 384497
42 renewalagreementapril320004.jpg GRAPHIC 52476
43 renewalagreementnovember001.jpg GRAPHIC 122812
44 renewalagreementnovember002.jpg GRAPHIC 417417
45 renewalagreementnovember003.jpg GRAPHIC 398120
46 renewalagreementnovember004.jpg GRAPHIC 31015
47 renewalagreementoctober1001.jpg GRAPHIC 88058
48 renewalagreementoctober1002.jpg GRAPHIC 413133
49 renewalagreementoctober1003.jpg GRAPHIC 384497
50 renewalagreementoctober1004.jpg GRAPHIC 52476
  Complete submission text file 0001657312-19-000007.txt   18937904

Data Files

Seq Description Document Type Size
11 XBRL INSTANCE DOCUMENT vrna-20181231.xml EX-101.INS 2575767
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrna-20181231.xsd EX-101.SCH 96021
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrna-20181231_cal.xml EX-101.CAL 88879
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrna-20181231_def.xml EX-101.DEF 405676
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrna-20181231_lab.xml EX-101.LAB 885791
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrna-20181231_pre.xml EX-101.PRE 600835
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-38067 | Film No.: 19690867
SIC: 2834 Pharmaceutical Preparations